Sherwin Sattarzadeh
Chief Operating Officer · Damora Therapeutics, Inc.
Individual
- 2026
- Jan 27, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sherwin Sattarzadeh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Jarrett - $253K in DMRA purchases and sales in the last 12 months
- Hans T. Schambye - $15K in DMRA purchases and sales in the last 12 months
- Garrett Winslow - $13K in DMRA purchases and sales in the last 12 months
- Lori Firmani - $3K in DMRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sherwin Sattarzadeh?
Sherwin Sattarzadeh is a corporate insider, tracked as Chief Operating Officer of Damora Therapeutics, Inc. (DMRA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Sherwin Sattarzadeh last file a Form 4?
The only primary Form 4 on record is dated 27 January 2026.
